BASF Adds Body-Care and Sunscreen Pacts as Evonik Standoff and Buyback Grind On
Published on 11/10/2026 at 17:21 | Editorial boerse-global.de
BASF has kept its dealmaking machinery running on several fronts this week, pairing two early-stage personal-care agreements with a fresh automotive seating concept, a Nanjing electronics investment and a green-power switch for its European polyisobutene output. The shares added 0.9% to €54.50 in today's trading, having earlier shown a 0.7% pre-market gain.
At the centre of the personal-care push is a memorandum of understanding signed today with Nox Bellcow Cosmetics to explore a strategic collaboration on innovation in body care. A day earlier, BASF put its name to a similar memorandum with S&J International Enterprises covering sun protection. Both documents are exploratory in nature — each is designed to test whether a deeper partnership makes sense before any commitment is made.
Automotive and electronics projects advance
On the automotive side, BASF worked with Hyundai Motor Company-Kia and Alten Korea on a concept car seat, unveiled yesterday as part of the Kia EV3 Study Car 2.0 project. The collaboration tests circular-economy materials and design approaches that make dismantling easier at end of life.
For its electronics materials business, BASF signed an investment agreement with the Nanjing Jiangbei New Area on 3 November covering a new production site in Nanjing. The plant is scheduled to come on stream by the end of 2028.
Should investors sell immediately? Or is it worth buying BASF?
Closer to home, the company said today it will switch its European polyisobutene production for external customers to electricity from renewable sources. The conversion is to be completed from January 2027 for the applicable Oppanol® B and Glissopal® products.
Legal reshuffle and a direct Evonik approach
Soeren Bauermann took charge of Corporate Legal, Compliance, Insurance & Security on 1 November, a remit spanning law, compliance, insurance and security, the company said.
Behind the scenes, the pursuit of Evonik has moved to the top table. According to Reuters, the chief executives and finance chiefs of both companies met on Saturday to discuss BASF's interest in acquiring Evonik, with the news agency reporting the encounter yesterday citing two sources. Evonik had previously turned down BASF's offer of €24 per Evonik share.
BASF at a turning point? This analysis reveals what investors need to know now.
Buyback passes 7.95 million shares
BASF's interim buyback report, published yesterday, showed roughly 352,000 own shares purchased in the previous week, covering trades from 2 to 6 November inclusive. Since the programme began on 3 August, the group has repurchased about 7.95 million shares, a total that runs through last Friday.
Investors will get their next set of hard numbers on 26 February 2027, when BASF publishes its 2026 annual report.
Ad
BASF Stock: New Analysis - 10 November
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
